In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles
Open Access
- 31 January 2007
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 43 (1), 184-193
- https://doi.org/10.1016/j.ejca.2006.08.029
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivoJournal of Hepatology, 2005
- Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseasesChemical Engineering Science, 2003
- Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticlesInternational Journal of Pharmaceutics, 2002
- Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin AInternational Journal of Pharmaceutics, 2001
- Chitosan nanoparticles as delivery systems for doxorubicinJournal of Controlled Release, 2001
- Biomaterials in Drug Delivery and Tissue Engineering: One Laboratory's ExperienceAccounts of Chemical Research, 1999
- Antibacterial Activity of Shrimp Chitosan against Escherichia coliJournal of Food Protection, 1999
- Treatment of hepatocellular carcinomaJournal of Hepatology, 1997
- Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverGastroenterology, 1992
- Antibacterial action of chitosanFood Biotechnology, 1992